Imatinib-induced eccrine squamous syringometaplasia.
Van de Voorde
Karen
K
De Raeve
Hendrik
H
Van Regenmortel
Niels
N
Lambert
Julien
J
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D003875:Drug Eruptions / Q000473:pathology*; D004439:Eccrine Glands / Q000473:pathology*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D008679:Metaplasia; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D013543:Sweat Gland Diseases / Q000139:chemically induced* / Q000473:pathology
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate